However, the most compelling data implicating CRP as a determinant of endothelial dysfunction has been obtained from studies demonstrating that human recombinant CRP reduced basal and stimulated nitric oxide (NO) release from arterial and venous endothelial cells. The gene discussed is CRP; the disease is endothelial dysfunction.